DNA 8-K: SEC filing

Ginkgo Bioworks

Filed with the SEC on Nov 5, 2026 · accession 0001628280-26-071022

DNA filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -14.5% by the first close after the filing.

Summary of the filing

Ginkgo Bioworks issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantGinkgo Bioworks Holdings, Inc.

Chief financial officerSteven Coen

How DNA stock reacted

Close before

$11.65

Nov 4, 2026

First close after

-14.51%

$9.96

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DNA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DNA?

Click here

Frequently asked questions

What did DNA file with the SEC on Nov 5, 2026?

DNA filed a 8-K (SEC filing). Ginkgo Bioworks issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did DNA stock react to this filing?

DNA closed at $11.65 before the filing and $9.96 on Nov 5, 2026 (-14.51%).

Other DNA SEC filings

Get alerts when DNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

DNA overview DNA analysis DNA news Latest SEC filings